{"id":3335,"date":"2023-07-19T13:30:28","date_gmt":"2023-07-19T16:30:28","guid":{"rendered":"https:\/\/www.atlanticpath.ca\/?p=3335"},"modified":"2023-07-19T13:30:28","modified_gmt":"2023-07-19T16:30:28","slug":"seroprevalence-in-canada-new-data-from-citf","status":"publish","type":"post","link":"https:\/\/www.atlanticpath.ca\/index.php\/2023\/07\/19\/seroprevalence-in-canada-new-data-from-citf\/","title":{"rendered":"Seroprevalence in Canada \u2013 New Data from CITF"},"content":{"rendered":"<p><em>&#8220;In order to tailor public health strategies to the current pandemic context, it is important to understand the prevalence of COVID-19 across Canada. Since the winter of 2021-22 with the onset of the Omicron wave, PCR testing for diagnosis of SARS-CoV-2 has failed to keep up with the rapid growth in infection across the population. The CITF has therefore drawn on serosurveillance studies (measuring antibodies due to infection and vaccination in a person\u2019s blood) to provide updated estimates of the magnitude and trends in SARS-CoV-2 infection in Canada.&#8221; (Source: CITF)<\/em><\/p>\n<p>Along with more than 20 studies, blood spot samples from Atlantic PATH participants and <span class=\"xv78j7m\" spellcheck=\"false\">CanPath<\/span> participants across the country helped to inform work from the COVID-19 Immunity Task Force that found that 78.5% of Canadians had antibodies due to infection by April 30, 2023.<\/p>\n<p>You can find an interactive map prepared by the Data and Analysis Team at the COVID-19 Immunity Task Force here: <a class=\"x1fey0fg xmper1u x1edh9d7\" href=\"https:\/\/www.covid19immunitytaskforce.ca\/seroprevalence-in-canada\/\">https:\/\/www.covid19immunitytaskforce.ca\/seroprevalence-in-canada\/<\/a><\/p>\n<p style=\"text-align: center;\"><img decoding=\"async\" class=\"aligncenter size-medium wp-image-3337\" src=\"https:\/\/www.atlanticpath.ca\/wp-content\/uploads\/2023\/07\/Infection-INduced-Seroprevlance-300x160.png\" alt=\"\" width=\"300\" height=\"160\" srcset=\"https:\/\/www.atlanticpath.ca\/wp-content\/uploads\/2023\/07\/Infection-INduced-Seroprevlance-300x160.png 300w, https:\/\/www.atlanticpath.ca\/wp-content\/uploads\/2023\/07\/Infection-INduced-Seroprevlance-768x409.png 768w, https:\/\/www.atlanticpath.ca\/wp-content\/uploads\/2023\/07\/Infection-INduced-Seroprevlance.png 1009w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><strong><em>COVID-19 Infection Induced Seroprevalence (Source: CITF)<\/em><\/strong><\/p>\n<p>Although Atlantic Canada had the lowest infection rates inthe country through most of the pandemic, the increases seen during the spring and summer of 2022 resulted in a seroprevalence comparable to other regions by fall 2022. This was due to a rate of increase in Atlantic Canada during the early Omicron waves that was higher than other regions.<\/p>\n<p>Please visit CITF for additional details from this work:\u00a0https:\/\/www.covid19immunitytaskforce.ca\/seroprevalence-in-canada\/<\/p>\n<p>#PopulationHealth #Cohorts #HealthResearch<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;In order to tailor public health strategies to the current pandemic context, it is important to understand the prevalence of COVID-19 across Canada. Since the winter of 2021-22 with the onset of the Omicron wave, PCR testing for diagnosis of SARS-CoV-2 has failed to keep up with the rapid growth in infection across the population. The CITF has therefore drawn on serosurveillance studies (measuring antibodies due to infection and vaccination in a person\u2019s blood) to provide updated estimates of the magnitude and trends in SARS-CoV-2 infection in Canada.&#8221; (Source: CITF) Along with more than 20 studies, blood spot samples from Atlantic PATH participants and CanPath participants across the country helped to inform work from the COVID-19 Immunity Task Force that found that 78.5% of Canadians had antibodies due to infection by April 30, 2023. You can find an interactive map prepared by the Data and Analysis Team at the COVID-19 Immunity Task Force here: https:\/\/www.covid19immunitytaskforce.ca\/seroprevalence-in-canada\/ COVID-19 Infection Induced Seroprevalence (Source: CITF) Although Atlantic Canada had the lowest infection rates inthe country through most of the pandemic, the increases seen during the spring and summer of 2022 resulted in a seroprevalence comparable to other regions by fall 2022. This was due to a rate of increase in Atlantic Canada during the early Omicron waves that was higher than other regions. Please visit CITF for additional details from this work:\u00a0https:\/\/www.covid19immunitytaskforce.ca\/seroprevalence-in-canada\/ #PopulationHealth #Cohorts #HealthResearch<\/p>\n","protected":false},"author":1,"featured_media":3337,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[3],"tags":[],"class_list":["post-3335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"modified_by":"pathwp","_links":{"self":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/comments?post=3335"}],"version-history":[{"count":6,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3335\/revisions"}],"predecessor-version":[{"id":3342,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3335\/revisions\/3342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/media\/3337"}],"wp:attachment":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/media?parent=3335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/categories?post=3335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/tags?post=3335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}